StevenAdesMD

Oncology • Burlington, VT

Professor, Medicine, University of Vermont College of Medicine

Join to view full profile

Dr. Ades is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ades' full profile

Already have an account?

Office
111 Colchester Ave
Hematologyoncology ACC Level 2
Burlington, VT 05401
Phone+1 802-847-8400

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
McGill University Faculty of MedicineClass of 1996

Certifications & Licensure

NY State Medical License 2024 - 2026
VT State Medical License 2007 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery Start of enrollment: 2006 Feb 01
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy Start of enrollment: 2009 Oct 01
Completed
Phase 2
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients Start of enrollment: 2009 Oct 01
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Phase II Study of Alternating Sunitinib and Temsirolimus Start of enrollment: 2010 Sep 22
Completed
Phase 2
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) Start of enrollment: 2012 Mar 01
Completed
Phase 2
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
Active, not recruiting
Phase 2, Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

57 citations
Statin therapy and levels of hemostatic factors in a healthy population: The Multi-Ethnic study of atherosclerosis
Nathan B. Adams, Pamela L. Lutsey, Aaron R. Folsom, David H Herrington, Christopher T. Sibley
Journal of Thrombosis and Haemostasis. 2013-06-01
6 citations
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Steven Ades, Daniel R. Douce, Chris E. Holmes, S. Cory, Shannon M. Prior
Journal of Thrombosis and Haemostasis. 2018-06-01
319 citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...
Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi
The Lancet. Oncology. 2021-07-01

Journal Articles

Cost-Effectiveness of Prostate Radiation Therapy for Men with Newly Diagnosed Low-Burden Metastatic Prostate Cancer
Nataniel H Lester-Coll, Steven Ades, James B Yu, JAMA Network Open

Abstracts/Posters

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention
Steven Ades, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Gastrointestinal (Noncolorectal) Cancer
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

How to Prevent a Cyberattack from Derailing Cancer CareOctober 1st, 2021
Non-Operative Management and Early Response Assessment in Rectal Cancer (NOM-ERA)December 8th, 2023

Professional Memberships

American Society of Clinical Oncology - ASCO
Member